What Does NMO Look and Feel Like?
Neuromyelitis Optica (NMO), also known as Devic's Disease, is a rare autoimmune disorder that primarily attacks the optic nerves and spinal cord. Because its symptoms can mimic other neurological conditions — most notably multiple sclerosis (MS) — it is frequently misdiagnosed, sometimes for years. Understanding the distinct symptom profile of NMO is the first critical step toward an accurate diagnosis and appropriate treatment.
The Two Core Manifestations
NMO is classically defined by two main attack types, often occurring in combination:
1. Optic Neuritis
Inflammation of one or both optic nerves causes sudden vision loss, eye pain (especially with movement), and altered color perception. NMO-related optic neuritis tends to be more severe than the MS variant, and recovery — if it occurs — may be incomplete, leaving lasting visual impairment.
2. Transverse Myelitis
Inflammation of the spinal cord produces a range of symptoms depending on the level affected:
- Limb weakness or paralysis (often affecting both legs or all four limbs)
- Sensory disturbances: numbness, tingling, burning pain
- Bladder and bowel dysfunction
- The "Lhermitte's sign" — an electric shock sensation down the spine when the neck is flexed
Additional Symptoms in NMOSD
NMO Spectrum Disorder (NMOSD) — the broader diagnostic category — can also present with:
- Intractable nausea and vomiting or hiccups: caused by lesions in the area postrema (a brainstem region unique to NMOSD)
- Narcolepsy or altered consciousness: from hypothalamic involvement
- Brainstem symptoms: double vision, facial numbness, hearing changes
How Is NMO Diagnosed?
Diagnosis relies on a combination of clinical history, imaging, and laboratory findings. The current internationally accepted criteria (revised 2015 IPND criteria) guide clinicians through a systematic process:
- MRI of the brain and spinal cord: NMO typically produces long spinal cord lesions spanning three or more vertebral segments (longitudinally extensive transverse myelitis, or LETM). Brain lesions, when present, tend to occur in characteristic regions unlike typical MS plaques.
- AQP4-IgG antibody testing: The aquaporin-4 antibody (anti-AQP4) is found in approximately 70–80% of NMOSD patients and is highly specific for the condition. A positive result strongly supports the diagnosis.
- MOG-IgG antibody testing: In AQP4-negative patients, testing for myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) identifies a related but distinct condition — MOGAD — which has overlapping features but different treatment implications.
- Cerebrospinal fluid (CSF) analysis: A lumbar puncture can reveal elevated white cell counts and protein levels during attacks, though findings are less specific than in MS.
- Visual evoked potentials (VEPs): Used to assess optic nerve function and document subclinical damage.
Differentiating NMO from MS
| Feature | NMO/NMOSD | Multiple Sclerosis |
|---|---|---|
| Spinal lesion length | ≥3 vertebral segments | Usually <2 segments |
| AQP4-IgG antibody | Often positive | Negative |
| Optic neuritis severity | Often severe, bilateral | Usually unilateral, milder |
| Course | Relapsing (rarely progressive) | Relapsing or progressive |
| Brain lesions pattern | Atypical for MS | Periventricular, juxtacortical |
When to Seek Specialist Evaluation
Anyone experiencing sudden, severe vision loss in one or both eyes combined with any spinal symptoms — particularly bladder or limb dysfunction — should seek urgent neurological evaluation. Early accurate diagnosis of NMO is critical: some MS disease-modifying drugs can actually worsen NMO, making correct identification potentially life-altering.